It would be fair to say that 2020 has been a bummer. What with the Australian fires and the Amazon burning; America almost going to war with Iran and then the humdinger – the Coronavirus Pandemic. People have experienced a multitude of challenges that they never had to before. COVID-19 has exposed each and every vulnerability of the world. Economies are collapsing, health is deteriorating and life is at an all-time high risk. Businesses have suffered massively and millions have lost their jobs. It is basically anarchy in the streets. We have all suffered enough and the only hope we are clinging on to is the find of the right vaccine for this deadly virus. In all honesty, it is as though we are hanging on to a long string of chewing gum. However, not all is lost because there is actually some genuinely good news. SHARP corporation has to its credit a proven state-of-the-art technology to reduce the risk of airborne virus transmission. SHARP’s patented Plasmacluster ion technology has established enough evidence of effectively reducing the spread of the novel Coronavirus.
Since the initial outbreak of the SARS-CoV-2 in December of 2019, more than 36 million have contracted the deadly disease and the world has seen over 1 million deaths. This pandemic is the deadliest we have seen in over a century. Face masks, social distancing and sanitisation of all public surfaces have proven effective to combat the virus but the world is still looking for a cure. In a world’s first, SHARP’s Plasmacluster technology that is used in their air purifiers – it has proven successful in neutralising more than 90% of the spread which is airborne. This is a huge breakthrough brought to the world with air purifying technology coming to the rescue.
SHARP’s Push for a Solution to COVID-19
SHARP Corporation has been, since the year 2000, advocating the effectiveness of its Plasmacluster technology with independent research organisations across the world. Especially In 2004, during the outbreak of the feline coronavirus (SARS-CoV^6), Plasmacluster technology demonstrated its effect successfully. This was also the case during the 2002-03 SARS outbreak of SARS-CoV^7 and now again against the novel coronavirus (SARS-CoV-2).
To achieve these successful results, SHARP has worked in collaboration with Professor Jiro Yasuda of the esteemed National Research Center for Control and Prevention of Infectious Diseases, Professor Asuka Nanbo (board member of Japanese Society for Virology) and Professor Hironori Yoshiyama, Faculty of Medicine in the Department of Microbiology of Shimani University. Their research is focussed on airborne infectious patterns rather than surface infectants. This is where Plasmacluster Technology has proved effective against deadly viruses.
A verification test for monitoring viral activity before and after being exposed to Plasmacluster ions was readied wherein aerosolised virus solution is concentrated in the close proximity to the Plasmacluster ion generator. After passing the virus through the said generator, the solution is then collected in a recovery device.
The final results were then calculated which revealed that viral activity reduced by a whopping 91.3%.
|Without Plasmacluster Ions||With Plasmacluster Ions||Reduction|
|1.76 x 104||1.54 x 103||91.3%|
Plasmacluster Technology Explained
Where SHARP has led the way is in its one-of-a-kind technology that makes use of Plasmacluster Ions. This technology was developed to combat the growing activity of allergens in the air around us in a manner that eliminates most of the viruses and bacteria. The working science behind this technology is as follows:
- Positive and negative charges are applied to discharge electrodes.
- The resultant airborne water and air molecules create positively charged Hydrogen ions and negatively charged Oxygen ions.
- Airborne water molecules cling to these ions in a cluster form – making them stable Plasmacluster ions.
- Plamsmacluster ions (made up of Positively charged Hydrogen ions and Negatively charged Oxygen ions) are released into the air.
- Allergens such as bacteria, fungi, viruses and others instantly bond to these ions and become Hydroxyl (OH) radicals.
- The high oxidizing power of these Hydroxyl radicals reduces the activity of bacteria and viruses up to 91.3% by breaking down their chemical reaction in the air.
(Source of the scientific findings are C/o Sharp Corporation, Japan)
SHARP-QNET ZENSational AIR PURIFIER – The Answer
SHARP in partnership with QNET India has successfully marketed and sold its flagship SHARP-QNET ZENSational Air Purifier on the QNET India eStore. It has been a stellar product in its line-up and has done exceptionally well especially with its patented Plasmacluster Ion Technology. Now that SHARP’s research has brought forward amazingly positive results, the ZENSational Air Purifier by SHARP-QNET is touted to be the best answer to negate the effects of the coronavirus.
Given that the COVID-19 virus can just as easily spread through the air like the common cold, it requires some serious beatdown. The solution is an air purifier that is built to kill pathogens in the air and equipped with high-density Plasmacluster ions to combat diseases such as H1N1, E. Coli, MRSA and now the SARS-CoV-2 Coronavirus. SHARP-QNET’s efforts to make a great air purifier has exceeded all expectations and has become the next big thing.
Finally, the world has an actually effective tool to feel safe from a deadly virus, whether it is at home, work or a medical facility. Thanks to the National Research Center for the Control and Prevention of Infectious Diseases/Institute of Tropical Medicine, Nagasaki University and its focussed study into how Plasmacluster ions can play a significant role in reducing pathogen activity in the air.
QNET India is proud to be associated with the marketing and direct selling of a product which has shown sufficient evidence of fighting the COVID-19 virus. Being part of the solution is indeed